We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+5.39%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$2.07B
AUM Growth
+$304M
Cap. Flow
+$228M
Cap. Flow %
11.06%
Top 10 Hldgs %
26.72%
Holding
186
New
38
Increased
42
Reduced
61
Closed
43

Top Buys

Rank Stock Value
1
HAE icon
Haemonetics
HAE
+$29.1M
2
FUN icon
Cedar Fair
FUN
+$27.5M
3
DV icon
DoubleVerify
DV
+$26.8M
4
CNMD icon
CONMED
CNMD
+$21.8M
5
XRAY icon
Dentsply Sirona
XRAY
+$20.7M

Top Sells

Rank Stock Value
1
AAP icon
Advance Auto Parts
AAP
+$29.3M
2
NGD
New Gold Inc
NGD
+$20.9M
3
WBD icon
Warner Bros
WBD
+$20.7M
4
VRNT
Verint Systems
VRNT
+$19.9M
5
M icon
Macy's
M
+$17.3M

Sector Composition

Rank Sector Weight
1 Technology 20.05%
2 Healthcare 18.45%
3 Consumer Discretionary 15.14%
4 Materials 10.18%
5 Industrials 8.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARKK icon
1
PUT
ARK Innovation ETF
ARKK
$5.74B
$104M 5.01%
+1,200,000
New +$91.7M
GPN icon
2
Global Payments
GPN
$23.9B
$56.6M 2.74%
681,094
+68,071
+11% +$5.73M
XRAY icon
3
Dentsply Sirona
XRAY
$2.7B
$55.2M 2.67%
4,351,199
+1,425,637
+49% +$20.7M
EGO icon
4
Eldorado Gold
EGO
$8.4B
$54.3M 2.63%
1,879,102
-152,795
-8% -$3.6M
VTRS icon
5
Viatris
VTRS
$20.8B
$53.6M 2.59%
5,413,109
+769,934
+17% +$7.49M
SPY icon
6
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$50.2M 2.43%
+75,400
New +$48.3M
ACHC icon
7
Acadia Healthcare
ACHC
$3.01B
$47.9M 2.32%
1,936,396
+568,796
+42% +$12.7M
TFX icon
8
Teleflex
TFX
$5.94B
$47.2M 2.28%
385,672
+101,287
+36% +$12.3M
RNG icon
9
RingCentral
RNG
$4.77B
$42M 2.03%
1,482,447
+55,088
+4% +$1.6M
PVH icon
10
PVH
PVH
$4.01B
$41.3M 2%
493,435
+78,983
+19% +$6.2M
CNXC icon
11
Concentrix
CNXC
$1.55B
$38M 1.84%
822,345
+135,429
+20% +$7.22M
AKAM icon
12
Akamai
AKAM
$16.3B
$37.8M 1.83%
499,097
+71,173
+17% +$5.49M
SON icon
13
Sonoco
SON
$5.99B
$36.3M 1.76%
843,451
+197,815
+31% +$9.14M
ST icon
14
Sensata Technologies
ST
$6.8B
$35.8M 1.73%
1,172,255
-21,312
-2% -$673K
BILL icon
15
BILL Holdings
BILL
$4.62B
$33.9M 1.64%
639,922
-4,640
-0.7% -$215K
EQX icon
16
Equinox Gold
EQX
$7.22B
$33.4M 1.62%
2,977,210
-640,874
-18% -$5.1M
CLVT icon
17
Clarivate
CLVT
$1.53B
$33.3M 1.61%
8,703,045
-682,042
-7% -$2.86M
LYFT icon
18
Lyft
LYFT
$5.87B
$31.1M 1.5%
1,411,677
-832,638
-37% -$13.9M
PENN icon
19
PENN Entertainment
PENN
$2.82B
$30.2M 1.46%
1,569,939
+101,028
+7% +$1.89M
MTB icon
20
M&T Bank
MTB
$36.6B
$29M 1.41%
146,967
-11,086
-7% -$2.18M
TNC icon
21
Tennant Co
TNC
$1.5B
$26.7M 1.29%
329,915
-20,549
-6% -$1.68M
UPWK icon
22
Upwork
UPWK
$1.21B
$24.8M 1.2%
+1,334,541
New +$19.9M
HAE icon
23
Haemonetics
HAE
$3.75B
$24.3M 1.18%
498,317
+470,502
+1,692% +$29.1M
SSYS icon
24
Stratasys
SSYS
$690M
$23.9M 1.16%
2,134,033
-536,540
-20% -$5.78M
VZ icon
25
Verizon
VZ
$201B
$23.7M 1.15%
538,964
+397,159
+280% +$17.2M
1
2 3 4 5

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return
SCP
Seizert Capital Partners Birmingham, Michigan $2.17B AUM 11.2% 1-Year Est. Return
OWP
Obermeyer Wealth Partners Aspen, Colorado $2.17B AUM 19.33% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
MMLI
Massachusetts Mutual Life Insurance Springfield, Massachusetts $2.17B AUM 48.68% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return

Invenomic Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Invenomic Capital Management held 186 positions worth $2.07B, up 17% from $1.76B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Invenomic Capital Management deployed $228M of net new capital in Q3 2025, opening 38 new positions and adding to 42 existing holdings. Its largest new stake was Cedar Fair: 1,034,288 shares worth $23.5M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Warner Bros, an estimated $20.7M trimmed.

  • Invenomic Capital Management's largest Q3 2025 buy was Cedar Fair: 1,034,288 shares worth $23.5M.
  • Invenomic Capital Management added most to Haemonetics in Q3 2025, an estimated $29.1M increase.
  • Invenomic Capital Management's biggest Q3 2025 reduction was Warner Bros, cutting an estimated $20.7M.
  • Invenomic Capital Management fully exited Advance Auto Parts in Q3 2025, selling an estimated $29.3M.
  • Invenomic Capital Management's ten largest holdings make up 27% of its $2.07B portfolio in Q3 2025.
  • Invenomic Capital Management opened 38 new positions and closed 43 in Q3 2025.
  • Invenomic Capital Management's portfolio value rose 17% quarter-over-quarter to $2.07B.

Based on Invenomic Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.